Elucidating the specific pharmacological system of action (MOA) of naturally taking place compounds could be tough. While Tarselli et al. (60) produced the primary de novo artificial pathway to conolidine and showcased that this naturally happening compound efficiently suppresses responses to both equally chemically induced and inflammation-derived